Czechia – Antineoplastic agents – Léčivé přípravky s obsahem nivolumabu a relatlimabu, cisplatiny, talazoparibu, ivoside
Fakultní nemocnice Hradec Králové awarded Kč25.5M to PROMEDICA PRAHA GROUP, a.s. for Professional Services & Consulting in December 2025 — one of 1,134 awards this buyer has made, above its typical award size.
Buying agency
Fakultní nemocnice Hradec KrálovéWinning supplier
PROMEDICA PRAHA GROUP, a.s.Contract description
Czechia – Antineoplastic agents – Léčivé přípravky s obsahem nivolumabu a relatlimabu, cisplatiny, talazoparibu, ivosidenibu, hydroxykarbamidu, afliberceptu, tebentafuspu
Related awards · Fakultní nemocnice Hradec Králové
1,134 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-319431-2026OHLA ŽS, a.s.Kč649M11 May 2026 Construction
- ocds-ted-531271-2025Merck Sharp & Dohme s.r.o.Kč577M13 Aug 2025 Professional Services
- ocds-ted-16820-2025VERTEX PHARMACEUTICALS (IRELAND) LIMITEDKč477M10 Jan 2025 Healthcare
Other wins · PROMEDICA PRAHA GROUP, a.s.
904 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-498283-2024Oblastní nemocnice Kolín, a.s., nemocnice Středočeského krajeKč197M20 Aug 2024 Professional Services
- ocds-ted-746939-2024Institut klinické a experimentální medicínyKč164M06 Dec 2024 Professional Services
- ocds-ted-508633-2024Oblastní nemocnice Kladno, a.s., nemocnice Středočeského krajeKč144M23 Aug 2024 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Fakultní nemocnice Hradec Králové and PROMEDICA PRAHA GROUP, a.s. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back